Schedule 13G ownership disclosure

FIVE PRIME THERAPEUTICS INC

Security class unavailable · CUSIP: 33830X104

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,305,554
Percent of class
12.0200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-16-000810
Form type
SC 13G/A
Filer
FIVE PRIME THERAPEUTICS, INC.
CIK
CIK 1175505
Filed
Feb 11, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub